A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway.
Isabele PardoPedro Brecheret FagundesRafael Santana de OliveiraPaulo Vidal CampregherPublished in: Einstein (Sao Paulo, Brazil) (2024)
Additional research specifically addressing issues related to toxicity and improving drug delivery methods is critical for the successful translation of these potential therapeutic targets into effective treatments for patients with triple-negative breast cancer.